Literature DB >> 10613744

Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis.

S De Vita1, V De Re, D Sansonno, D Sorrentino, R L Corte, B Pivetta, D Gasparotto, V Racanelli, A Marzotto, A Labombarda, A Gloghini, G Ferraccioli, A Monteverde, A Carbone, F Dammacco, M Boiocchi.   

Abstract

The hepatitis C virus (HCV) has been linked to B-cell lymphoproliferation and autoimmunity, and has been localized in several tissues. The clinical observation of an HCV-infected patient with Sjögren's syndrome (SS) and Helicobacter pylori (HP) positive gastric low-grade B-cell non-Hodgkin's lymphoma (NHL), which did not regress after HP eradication, led us to investigate the possible localization of HVC in the gastric microenvironment. HCV genome and antigens were searched in gastric biopsy specimens from the previously mentioned case, as well as from 9 additional HCV-infected patients (8 with chronic gastritis and 1 with gastric low-grade B-cell NHL). HCV-specific polymerase chain reaction (PCR) and immunohistochemistry procedures were used. The gastric B-cell NHL from the patient with SS was characterized by molecular analyses of B-cell clonality. HCV RNA was detected in both the gastric low-grade B-cell NHL and in 3 out of 6 gastric samples from the remaining cases. HCV antigens were detected in the residual glandular cells within the gastric B-cell NHL lesions, in glandular cells from 2 of the 3 additional gastric lesions that were HCV positive by PCR, and in 1 additional chronic gastritis sample in which HCV-RNA studies could not be performed. By molecular analyses, of immunoglobulin genes, the B-cell NHL from the patient with SS was confirmed to be a primary gastric lymphoma, subjected to ongoing antigenic stimulation and showing a significant similarity with rheumatoid factor (RF) and anti-HCV- antibody sequences. Our results show that HCV can localize in the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10613744     DOI: 10.1002/hep.510310127

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; M Montrone; F A Tucci; L Nisi; F Dammacco
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 2.  The spectrum of gastric disease associated with Helicobacter pylori and other infectious gastritides.

Authors:  Jeannette Guarner
Journal:  Curr Gastroenterol Rep       Date:  2004-12

3.  Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C.

Authors:  Yuichi Honma; Michihiko Shibata; Kahori Morino; Yudai Koya; Tsuguru Hayashi; Noriyoshi Ogino; Masashi Kusanaga; Shinji Oe; Koichiro Miyagawa; Shintaro Abe; Akinari Tabaru; Masaru Harada
Journal:  Dig Dis Sci       Date:  2022-09-14       Impact factor: 3.487

4.  Some patients with NHL possessed immunoreactivity to gliadin and to cow's milk proteins.

Authors:  Zorica D Juranić; Irina Besu; Svetislav Jelić; Aleksandra Konić-Ristić; Suzana Matković; Ljiljana Janković; Dušica Gavrilović; Branka Radojčić; Ivana Minić
Journal:  Int J Hematol       Date:  2009-07-17       Impact factor: 2.490

Review 5.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

6.  Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins.

Authors:  Keigo Machida; Kyoko Tsukiyama-Kohara; Satoshi Sekiguch; Eiji Seike; Shigenobu Tóne; Yukiko Hayashi; Yoshimi Tobita; Yuri Kasama; Masumi Shimizu; Hidemi Takahashi; Chyoji Taya; Hiromichi Yonekawa; Nobuyuki Tanaka; Michinori Kohara
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

Review 7.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

8.  Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2).

Authors:  Mohamed Tarek M Shata; Enass A Abdel-Hameed; Helal F Hetta; Kenneth E Sherman
Journal:  J Clin Pathol       Date:  2013-08-12       Impact factor: 3.411

Review 9.  Cryoglobulinemia related to hepatitis C virus infection.

Authors:  Maria Pina Dore; Giovanna Fattovich; Antonia R Sepulveda; Giuseppe Realdi
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.487

10.  A tailored health surveillance program unveils a case of MALT lymphoma in an HCV-positive health-care worker.

Authors:  Venerando Rapisarda; Andrea Marconi; Saverio Candido; Daria Nicolosi; Mario Salmeri; Pietro Gangemi; Lidia Proietti; Demetrios A Spandidos; Massimo Bracci; Cettina Fenga; Massimo Libra
Journal:  Oncol Lett       Date:  2012-11-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.